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Suppressor of cytokine signaling 1 (SOCS1) is a recently identiﬁed host factor that positively regu-
lates the intracellular trafﬁcking and stability of HIV-1 Gag. We here examine the molecular mech-
anism by which SOCS1 regulates intercellular Gag trafﬁcking and virus particle production. We ﬁnd
that SOCS1 colocalizes with Gag along the microtubule network and promotes microtubule stability.
SOCS1 also increases the amount of Gag associated with microtubules. Both nocodazole treatment
and the expression of the microtubule-destabilizing protein, stathmin, inhibit the enhancement
of HIV-1 particle production by SOCS1. SOCS1 facilitates Gag ubiquitination and the co-expression
of a dominant-negative ubiquitin signiﬁcantly inhibits the association of Gag with microtubules.
We thus propose that the microtubule network plays a role in SOCS1-mediated HIV-1 Gag transport
and virus particle formation.
Structured summary:
MINT-7014185: Gag (uniprotkb:P05888) and SOCS1 (uniprotkb:O15524) colocalize (MI:0403) by cosedi-
mentation (MI:0027)
MINT-7014239: Cullin 2 (uniprotkb:Q13617) physically interacts (MI:0218) with RelA (uni-
protkb:Q04206), RBX1 (uniprotkb:P62877), SOCS1 (uniprotkb:O15524), elongin B (uniprotkb:Q15369)
and elongin C (uniprotkb:Q15370) by pull-down (MI:0096)
MINT-7014046: gag (uniprotkb:P05888), SOCS1 (uniprotkb:O15524) and tubulin alpha (uni-
protkb:Q13748) colocalize (MI:0403) by ﬂuorescence microscopy (MI:0416)
MINT-7014269: tubulin alpha (uniprotkb:Q13748) physically interacts (MI:0218) with Gag (uni-
protkb:P05888) by anti tag coimmunoprecipitation (MI:0007)
MINT-7014036: tubulin alpha (uniprotkb:Q13748) and SOCS1 (uniprotkb:O15524) colocalize (MI:0403) by
ﬂuorescence microscopy (MI:0416)
MINT-7014201: Cullin 2 (uniprotkb:Q13617) physically interacts (MI:0218) with RBX1 (uni-
protkb:P62877), SOCS1 (uniprotkb:O15524), elongin B (uniprotkb:Q15369) and elongin C (uni-
protkb:Q15370) by pull-down (MI:0096)
MINT-7014257: Gag (uniprotkb:P05888) physically interacts (MI:0218) with Ubiquitin (uni-
protkb:P62988) by anti tag coimmunoprecipitation (MI:0007)
MINT-7014221: Cullin 2 (uniprotkb:Q13617) physically interacts (MI:0218) with Gag (uniprotkb:P05888),
elongin C (uniprotkb:Q15370), elongin B (uniprotkb:Q15369), SOCS1 (uniprotkb:O15524) and RBX1 (uni-
protkb:P62877) by pull-down (MI:0096)
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The human immunodeﬁciency virus 1 (HIV-1) employs multi-
step and multi-factorial processes for producing progeny viruses
during infection [1,2]. Virus must utilize the intrinsic transport
machinery of the infected host cells to enable the active transportlsevier B.V. All rights reserved.
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lar factors that modulate HIV-1 Gag trafﬁcking and localization.
These include AP-3d, POSH, HP68, GGA and Trim22 [5–9]. More-
over, phosphatidylinositol-(4,5)-bisphosphate (PIP2) has been
shown to control the targeting of Gag to the plasma membrane
[10]. These ﬁndings point to a critical role of host cell factors in
Gag assembly and release, but the precise molecular functions of
these factors and the speciﬁc timing of their roles in this process
remain largely unknown.
We recently reported that the suppressor of cytokine signaling
1 (SOCS1) is an inducible host factor during HIV-1 infection and
plays an important role in the intracellular trafﬁcking of Gag to
the plasma membrane, resulting in the efﬁcient production of
HIV-1 particles [11]. Moreover, we have further shown that the
function of SOCS1 in Gag trafﬁcking and HIV-1 particle production
is not principally due to the suppression of interferon/cytokine sig-
naling, but is mediated via its interaction with the HIV-1 Gag poly-
protein [11]. Importantly, the targeted depletion of SOCS1 results
in the mistargeting and degradation of Gag in lysosomes, leading
to a signiﬁcant decrease in virus particle production [11].
In our current study, we have utilized SOCS1 as a molecular tool
to further reveal the molecular mechanisms underlying the intra-
cellular transport of HIV-1 Gag during viral infection. We reveal
from our ﬁndings that SOCS1 regulates the Gag trafﬁcking process
via the microtubule-dependent cellular machinery. Furthermore,
we ﬁnd that Gag is also regulated by a ubiquitin signaling pathway
which is accompanied by Gag ubiquitination. These ﬁndings shed
new light on themechanisms involved in the intracellular transport
of HIV-1 Gag and provide important clues for the design of future
novel therapeutic interventions against AIDS and related disorders.
2. Materials and methods
2.1. Antibodies
Antibodies (Abs) and ﬂuorescent reagents were obtained from
the following sources: rabbit polyclonal anti-myc (A-14) and rabbit
polyclonal anti-SOCS1 (H-93) Abs (Santa Cruz Biotechnology); rab-
bit polyclonal anti-SOCS1 (Zymed Laboratories); mouse monoclo-
nal anti-FLAG (M2), anti-a-tubulin, anti-acetylated-a-tubulin and
anti-c-tubulin Abs (Sigma, St. Louis, MO); rabbit polyclonal anti-
stathmin antibody (Calbiochem); mouse monoclonal anti-myc
antibody (9B11, Cell Signaling Technology); mouse monoclonal
anti-cytokeratin 7, cytokeratin 18, vimentin and HIV-p24 Ab (Dako
Cytomation). Immunoblotting, immunoprecipitation and immuno-
ﬂuorescent analyses were performed as described previously [11].
2.2. Plasmids and sequences
Expression constructs for SOCS1 have been described previ-
ously [12]. HIV-1 Gag constructs have also been described
previously [13]. Stathmin cDNA was ampliﬁed by RT-PCR from a
human kidney cDNA library using the primers 50-AGCAAG
CTTGCCACCATGGCTTCTTCTGATATCCAGG-30 and 50-GACGGATCC
GTCAGCTTCAGTCTCGTCAG-30 and then subcloned into the
pcDNA3.1 vector. pcDNA3.1-myc-ubiquitin and its mutants were
generated by PCR as described previously [14]. The siRNA se-
quences were as follows: SOCS1-siRNA, GGCCAGAACCTT
CCTCCTCTT; control-siRNA, TCGTATGTTGTGTGGAATT. All expres-
sion constructs were validated by sequencing.2.3. Microtubule-associated protein spin-down assays
Microtubule-associated proteins were collected using a micro-
tubule-associated protein spin-down assay kit (Cytoskeleton,BK029) according to the manufacturer’s instructions. Brieﬂy,
293T cells were lysed in 0.5 ml of PEM buffer (80 mM PIPES, pH
6.9, 0.3% Triton X-100, 1 mM EGTA, 1 mM GTP, GTP, 1 mM MgCl2)
supplemented with 1 mM phenylmethylsulfonyl ﬂuoride, 5 lg/ml
leupeptin, 2 lg/ml aprotinin, 1 mM sodium orthovanadate, and
5 mMNaF. Cell lysates were incubated with taxol-stabilized micro-
tubules, followed by ultracentrifuge at 100000g for 40 min at
25C.
2.4. Cell culture
The 293T, COS-1, COS-7, HeLa and HOS cell lines and mouse
embryonic ﬁbroblasts (MEFs) were cultured in DMEM supple-
mented with 10% FBS. SOCS1/ MEF cells were cultured as de-
scribed previously [12].
2.5. In vitro interaction analysis
The in vitro interaction between HIV-1 Gag and the SOCS1-E3
complex was analyzed as follows: 14C-labeled recombinant pro-
teins (SOCS1, elongin B/C, Rbx1, biotin labeled cullin 2, and HIV-
1 Gag) were synthesized in a wheat germ cell-free system as de-
scribed previously [15]. The synthesized proteins were subse-
quently incubated in 120 ll of reaction buffer (50 mM Tris–HCl,
pH 7.6, 50 mM MgCl2, 500 mM CH3COOK, 0.1 mM DTT and 1 mg/
ml BSA) and streptavidin magnetic beads (Promega, Madison,
WI) at 23 C for 1 h. The precipitated proteins were then washed
three times with reaction buffer and subjected to autoradiography.
3. Results
3.1. SOCS1 aligns with microtubule forming ﬁbrous structures
SOCS1 has been shown previously to localize at both the perinu-
clear region and the microtubule organizing center (MTOC) [16].
This ﬁnding indicated the possible involvement of the microtubule
network in the regulation of Gag by SOCS1. We thus addressed
whether the Gag transport system is in fact mediated by microtu-
bule integrity and if SOCS1 enhances this process. Immunoﬂuores-
cent analysis with a-tubulin antibodies revealed that endogenous
SOCS1 forms punctate structures that align with the microtubule
network (Fig. 1A). Importantly, these signals were completely abol-
ished when the cells were stained with anti-SOCS1 antibodies that
had been pre-absorbed with recombinant SOCS1 protein, conﬁrm-
ing the speciﬁcity of this antibody (Fig. 1B). Parallel experiments re-
vealed that SOCS1 does not colocalize with other cytoskeletal
components such as actin or intermediate ﬁlaments (Fig. 1C).3.2. SOCS1 promotes microtubule stability
Given our ﬁnding that SOCS1 can tightly associate with micro-
tubules, we next addressed whether SOCS1 affects microtubule
stability. Stabilized microtubules are frequently enriched in tubu-
lin that has undergone post-translational modiﬁcations such as
acetylation [17]. We found that the high expression of SOCS1 re-
sults in higher amounts of acetylated microtubules in three differ-
ent cell lines when compared with control cells (Fig. 2A) and that
this trend is dose-dependent in COS-7 cells (Fig. 2B). On the other
hand, SOCS1/ mouse embryonic ﬁbroblasts (MEFs) exhibited
lower levels of acetylated a-tubulin compared with wild-type
MEFs (Fig. 2C). These results indicate that SOCS1 does indeed con-
tribute to the stabilization of microtubules.
Mammalian cells usually possess a population of microtubules
that are resistant to the depolymerization effects of microtubule
disorganizing reagents. We thus addressed whether SOCS1 impacts
Fig. 1. SOCS1 colocalizes with microtubule forming ﬁbrous structures. (A) COS-1 cells were ﬁxed with 3% formaldehyde followed by 100% cold methanol, and then co-
immunostained with polyclonal antibodies targeting SOCS1 (red) and monoclonal antibodies targeting a-tubulin (green). Cells were then analyzed by confocal microscopy.
Scale bar, 10 lm. (B) COS-1 cells were immunostained with anti-a-tubulin monoclonal antibodies together with anti-SOCS1 polyclonal antibodies that had either been non-
absorbed or pre-absorbed with GST-SOCS1 proteins. This was followed by confocal microscopy. Scale bar, 10 lm. (C) COS-1 cells were ﬁxed with 3% formaldehyde followed
by 100% cold methanol, then co-immunostained with polyclonal antibodies targeting SOCS1 (red) and monoclonal antibodies targeting various cytoskeletal components
(green). Cells were then analyzed by confocal microscopy.
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cells. The cells were transfected with either SOCS1 or control vec-
tor and then treated with 1 lM colchicine for 12 h to fully depoly-
merize the microtubules. Immunostaining with antibodies against
acetylated a-tubulin showed that the SOCS1 expressing cells con-
tained more polymerized microtubules compared with the control
cells (Fig. 2D). These results indicate that SOCS1 might contribute
to the microtubule stability required for Gag trafﬁcking via this
network.
3.3. SOCS1 enhances the association of HIV-1 Gag with microtubules
We next investigated the sub-cellular localization of HIV-1 Gag
with SOCS1 and microtubules. COS-1 cells were transfected with
Gag-GFP and after 24 h were ﬁxed with 3% formaldehyde, followed
by 100% cold methanol. The cells were then immunostained with
anti-SOCS1 and anti-a-tubulin antibodies. Consistent with our ear-
lier results, confocal microscopic analysis revealed that SOCS1 can
form dotted ﬁlamentous structures in the cytoplasm along themicrotubules, and that HIV-1 Gag colocalizes with these SOCS1
puncta (Fig. 3A).
To next determine whether cellular SOCS1 and Gag can together
mechanically bind microtubules, and thus whether SOCS1 expres-
sion has any impact upon the interaction between Gag and micro-
tubules, we performed microtubule pull-down analysis. 293T cells
were transfected with either Gag-FLAG, myc-SOCS1, or a combina-
tion of these two plasmids, and the lysates from these transfected
cells were subsequently incubated with taxol-stabilized microtu-
bules and centrifuged to pellet the microtubule-associated
proteins. The pellet fractions were then subjected to immunoblot-
ting using either anti-myc or anti-FLAG antibodies. SOCS1 was
found to be co-sedimented with microtubules irrespective of
whether Gag had been co-transfected (Fig. 3B). The quantities of
microtubule-bound Gag in the pellet fraction, however, were sig-
niﬁcantly increased when SOCS1 was co-transfected (Fig. 3B).
These results together indicate that SOCS1 is itself a microtubule
binding protein that may also mediate the interaction between
HIV-1 Gag and microtubules.
Fig. 2. SOCS1 enhances microtubule stability. (A) COS-7, HeLa or HOS cells were transfected with either empty vector or myc-SOCS1 for 48 h. Cell lysates were then subjected
to immunoblotting analysis with antibodies against a-tubulin, acetylated a-tubulin or SOCS1. (B) COS-7 cells were transfected with various amounts of myc-SOCS1 as in (A).
Cell lysates were then subjected to immunoblotting analysis with anti-a-tubulin, anti-acetylated-a-tubulin or anti-myc antibodies. Numerical values below the blots indicate
acetylated a-tubulin signal intensities normalized by the unmodiﬁed a-tubulin intensity derived by densitometry. (C) Exponentially growing wild-type MEFs or SOCS1/
MEFs were lysed and the cell lysates were immunoblotted with antibodies against a-tubulin, acetylated a -tubulin or SOCS1. (D) COS-7 cells were co-transfected with empty
vector or myc-SOCS1, and then treated with colchicine (1 lM) for 12 h to depolymerize the microtubules. Cells were then ﬁxed and immunostained with both anti-
acetylated-a-tubulin (green) or anti-myc (red) antibodies and then stained with 40 ,6-diamino-2-phenylindole (DAPI, blue), followed by confocal microscopy. Scale bar, 10 lm.
Fig. 3. SOCS1 enhances HIV-1 Gag associated with microtubules. (A) COS-1 cells transiently transfected with HIV-1 Gag-GFP were co-immunostained with antibodies
targeting endogenous SOCS1 (red) and microtubules (a-tubulin, blue). The inset indicates the area shown at higher magniﬁcation in the right hand panels which reveal the
colocalization of Gag-GFP with SOCS1 along the microtubules. Scale bar, 10 lm. (B) Cosedimentation of SOCS1 and HIV-1 Gag with polymerized microtubules. 293T cells were
transfected with the indicated plasmids for 36 h. Cell lysates were then incubated with taxol-stabilized microtubules or control buffer and separated into precipitate (PPT)
and supernatant fractions. Precipitate fractions were subjected to immunoblotting analysis with anti-myc or anti-FLAG antibodies.
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particle formation
Our results shown above indicated that SOCS1 mediates the
association of HIV-1 Gag with the microtubule networks. We next
examined therefore whether SOCS1-mediated Gag trafﬁcking, and
the resultant HIV-1 particle production, are dependent upon an in-
tact microtubule network. 293T cells were transfected with theHIV-1 molecular clone pNL4-3 and co-transfected with either
empty vector alone or myc-SOCS1. After 24 h, the cells were
washed with PBS and then cultured in the presence or absence of
nocodazole for a further 6 h. Subsequent measurement of the
p24 antigen levels in the cell supernatant by ELISA revealed noco-
dazole treatment signiﬁcantly inhibited the enhancement of HIV-1
particle production in SOCS1-transfected cells more dramatically
than in vector control transfected cells, and that this was
M. Nishi et al. / FEBS Letters 583 (2009) 1243–1250 1247dose-dependent (Fig. 4A). Consistent with these results also, SOCS1
localization was observed to be signiﬁcantly altered by nocodazole
treatment, i.e. from a dotted ﬁlamentous structure along theFig. 4. Microtubule integrity is required for SOCS1 to function in HIV-1 particle formation
vector alone (Vector) or myc-SOCS1. After 24 h, cells were washed with PBS and then cul
Supernatant p24 antigen levels were measured by p24 ELISA . The data shown are the av
and C) Mislocalization of SOCS1 in cells treated with nocodazole. COS-1 cells were treate
immunostained with both anti-SOCS1 (red) and anti-a-tubulin (green) antibodies, follow
calculated by trypan blue dye exclusion (C). (D) COS-1 cells transfected with Gag-GFP
immunostaining with anti-a-tubulin (red) antibody. Scale bar, 10 lm. (E and F) 293T cell
various amounts of stathmin. At 36 h after transfection, cell lysate and supernatant virus
PARP, anti-b-actin or anti-stathmin antibodies (E). VLP p24 Gag signal intensities, derivemicrotubules to diffuse and larger aggregations in the cytoplasm
(Fig. 4B). The use of trypan blue dye exclusion conﬁrmed that cell
viability was not affected by the nocodazole treatment (Fig. 4C).. (A) 293T cells were transfected with pNL4-3, and co-transfected with either empty
tured with fresh media including the indicated concentrations of nocodazole for 6 h.
erage ± S.D. of three independent experiments. *P 6 0.05, by the Student’s t-test. (B
d with vehicle only or with nocodazole (2 lg/ml) for 6 h. Cells were then ﬁxed and
ed by confocal microscopy (B). Scale bar, 10 lm. The numbers of viable cells were
were treated with vehicle only or with nocodazole (2 lg/ml) for 6 h followed by
s were transfected with pNL4-3 and either vector or SOCS1, and co-transfected with
-like particle (VLP) were processed for immunoblotting analysis with anti-p24, anti-
d by densitometry, are shown in (F).
Fig. 5. SOCS1 enhances the ubiquitination of HIV-1 Gag and this affects the association of Gag with the microtubules. (A) Schematic represenation of SOCS1 mutants. (B) 293T
cells were transfected with pNL4-3 and co-transfected with control vector, wild-type SOCS1 (WT), SOCS1-F59Dmutant orDSOCS-box mutant. After 48 h, the p24 levels in the
cell supernatants were measured by ELISA. (C) HIV-1 Gag associates with the ubiquitin ligase complex of SOCS1 in vitro. 14C-labeled proteins (SOCS1, biotin labeled Cullin2,
elongin B/C, Rbx1, HIV-1 Gag and RelA) were synthesized using a wheat germ cell-free system. Puriﬁed proteins were incubated in the indicated combinations for 1 h and
subjected to co-puriﬁcation with streptavidin magnetic beads. Captured proteins were then separated by SDS–PAGE followed by autoradiography. (D) 293T cells were co-
transfected with Gag-FLAG, myc-tagged ubiquitin, and either empty vector (Vector) or SOCS1 expression construct. After 48 h, cells were lysed and denatured by boiling them
in 1% SDS lysis buffer and diluted to RIPA buffer conditions, and Gag-FLAG proteins were immunoprecipitated (IP) with anti-FLAG antibody and processed for anti-myc
immunoblotting to detect ubiquitinated Gag. Ubn, polyubiquitinated. Numerical values below blot indicates the relative levels of ubiquitinated Gag normalized by the
amount of total Gag. (E) 293T cells were co-transfected with Gag-FLAG, myc-tagged ubiquitin, and either control-siRNA or SOCS1-siRNA. After 48 h, cell lysates were
immunoprecipitated with anti-FLAG antibody and processed for anti-myc immunoblotting to detect ubiquitinated Gag. Ubn, polyubiquitinated. Numerical values below blot
indicates the relative levels of ubiquitinated Gag normalized by the amount of total Gag. (F) 293T cells were transfected with Gag-GFP and SOCS1, and co-transfected with
either myc-Ub-WT or myc-UbDGG. After 24 h, cell lysates were harvested and subjected to immunoprecipitation analysis with anti-a-tubulin antibody or non-immunized
mouse IgG (IgG) followed by immunoblotting analysis with the indicated antibodies. (G) 293T cells were transfected with Gag-FLAG and SOCS1, and co-transfected with
either myc-Ub-WT or myc-UbDGG. After 24 h, cell lysates were harvested and then incubated with taxol-stabilized microtubules (+MT) or control buffer (MT), and
separated into precipitate and supernatant fractions. Precipitate fractions were collected and then subjected to immunoblotting analysis with either anti-FLAG or anti-a-
tubulin (microtubule) antibodies.
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puncta formed larger aggregations in the cytoplasm upon nocodaz-
ole treatment (Fig. 4D).
To further delineate the role of microtubule integrity in HIV-1
particle formation, we next performed experiments in which we
co-transfected SOCS1 and pNL4-3 with or without the microtu-
bule-destabilizing protein stathmin. Stathmin expression efﬁ-
ciently blocked the effects of SOCS1 upon HIV-1 particle
formation in a dose-dependent manner (Fig. 4E and F). Cell viabil-
ity was not strongly affected as revealed by immunoblotting anal-
ysis of either poly (ADP-ribose) polymerase (PARP) or b-actin
(Fig. 4E). Our ﬁndings together indicate therefore that microtubule
integrity may be required for SOCS1 to function in Gag assembly
and release.
3.5. SOCS1 facilitates the ubiquitination of HIV-1 Gag
Our previous study has revealed that the SOCS-box of SOCS1 is
required for both HIV-1 particle production and the enhancement
of Gag association with microtubules [11]. The mechanism by
which SOCS1 inhibits cytokine signaling is mediated by the inhibi-
tion of kinase activity through its N-terminal kinase inhibitory re-
gion (KIR) [18]. We next examined whether SOCS1 mutants lacking
the function of either KIR (SOCS1-F59D) or SOCS-box (DSOCS) af-
fected virus particle production. Our ELISA results indicate that
the SOCS-box deletion mutant (DSOCS) of SOCS1 fails to promote
virus production, whereas the KIR mutant, F59D, of SOCS1 partially
enhances HIV-1 particle production when co-transfected with
pNL4-3 in 293T cells (Fig. 5A and B). These data again suggest that
the function of SOCS1 in HIV-1 particle production is not princi-
pally due to the suppression of interferon/cytokine signaling, but
is mediated by its direct interaction with the HIV-1 Gag via the
function of the SOCS-box.
The SOCS-box-mediated function of SOCS1 is chieﬂy exerted via
its ubiquitin ligase activity [19]. Indeed, several reports have dem-
onstrated that Gag ubiquitination is related to its membrane asso-
ciation and particle release, although the function of HIV-1 Gag
ubiquitination remains unclear [20,21]. We thus explored the pos-
sibility that SOCS1 modulates the ubiquitination of HIV-1 Gag,
leading to enhanced virus particle formation. We initially exam-
ined the speciﬁc interaction of HIV-1 Gag with the SOCS1-E3 ligase
complex. Puriﬁed SOCS1 and its E3 component proteins (biotinyl-
ated-Cullin 2, elongin B/C and Rbx1) in addition to HIV-1 Gag were
synthesized in a wheat germ cell-free system and then subjected to
pull-down assays using streptavidin coated magnetic beads. We
found that Gag was co-puriﬁed with a SOCS1-E3 complex compris-
ing SOCS1-elongin B/C-Rbx1-Cullin2 in a similar manner to RelA, a
previously reported SOCS1 binding protein (Fig. 5C, left). Signiﬁ-
cantly, in the absence of SOCS1, both elongin B and C were not
co-puriﬁed with Cullin 2 probably due to the unsteady condition
of the E3 complex without SOCS1, and the amount of bound Gag
was also reduced (Fig. 5C, right).These result indicate that the
SOCS1-E3 complex associates with HIV-1 Gag and may promote
its ubiquitination.
We next addressed whether SOCS1 affects the ubiquitination of
HIV-1 Gag. Immunoprecipitation analysis with cells co-transfected
with Gag-FLAG and myc-tagged ubiquitin, with or without SOCS1
co-transfection, revealed that SOCS1 overexpression signiﬁcantly
enhances the ubiquitination of the Gag protein (Fig. 5D). In con-
trast, the targeted depletion of SOCS1 by siRNA signiﬁcantly re-
duced the amount of ubiquitinated Gag (Fig. 5E). These results
indicate that SOCS1 could indeed be a potent ubiquitin ligase for
HIV-1 Gag.
To clarify the biological signiﬁcance of Gag ubiquitination via
SOCS1, we performed an experiment using a dominant-negative
ubiquitin construct lacking two C-terminal glycines (residues 75–76). This mutant ubiquitin (UbDGG) cannot become conjugated
to target substrates, but can bind noncovalently to ubiquitin inter-
acting domains [14]. By immunoprecipitation analysis we revealed
that the levels of HIV-1 Gag associated with microtubules were sig-
niﬁcantly reduced in cells expressing UbDGG, as compared with
those expressing wild-type ubiquitin (Ub-WT) (Fig. 5F). This trend
was further revealed by a microtubule sedimentation experiment
showing that the expression of UbDGG reduced the amount of
Gag associated with microtubules when compared with the
expression of Ub-WT (Fig. 5G). These results together indicate a
link between ubiquitin signaling and the microtubule-mediated
Gag dynamics involved with HIV-1 particle formation.4. Discussion
In our current study, we report that microtubule integrity is re-
quired for SOCS1 to facilitate Gag trafﬁcking and virus particle pro-
duction. We demonstrate from our experiments that (1) SOCS1
colocalizes with HIV-1 Gag along microtubules; (2) both SOCS1
and HIV-1 Gag are co-puriﬁed with microtubules and SOCS1 can
augment the association of Gag with microtubules; (3) an intact
microtubule network is required for the function of SOCS1 during
Gag trafﬁcking; (4) SOCS1 facilitates Gag ubiquitination; and (5)
Gag association with the microtubules is signiﬁcantly reduced
when a dominant-negative Ub mutant is overexpressed. These re-
sults together indicate that SOCS1 can regulate the trafﬁcking and
stability of HIV-1 Gag via the microtubule-related cellular machin-
ery, which may be in turn enhanced by Gag ubiquitination.
SOCS1 was identiﬁed initially as a negative regulator of signal-
ing downstream of cytokines [22–24] and has been shown to local-
ize at both the perinuclear region and the microtubule organizing
center (MTOC) in cells [16]. We show from our current data that
SOCS1 also forms dotted ﬁlamentous structures in the cytoplasm
emanating from the perinuclear region, including the MTOC, to
the cell periphery. A recent report has also indicated that Gag colo-
calizes at the MTOC with HIV-1 RNA and is subsequently trans-
ported to the cell periphery [25]. These observations together
indicate that SOCS1 might facilitate the trafﬁcking of HIV-1 Gag
from the MTOC toward the plasma membrane by utilizing the
intrinsic transport machinery of infected host cells.
The plus-end directed transport system along the microtubules
could provide a means for the targeting of virus capsid proteins to
the site of virus assembly and budding in the vicinity of the plasma
membrane [26]. This ante-grade transport system is utilized by
several viruses, such as herpes simplex virus type 1 (HSV-1), vac-
cinia virus and African swine fever virus (ASFV) [26–29]. Signiﬁ-
cantly, we have demonstrated in our present study that HIV-1
can utilize the microtubule-dependent transport mechanism,
which may in turn be enhanced by SOCS1. Consistent with this no-
tion, Leblanc et al. have demonstrated previously using a monoclo-
nal antibody raised against unprocessed Gag that intracellular Gag
puncta can travel along microtubules [30]. Our current microtu-
bule pull-down analyses also clearly indicate that SOCS1 associates
with Gag on microtubules and can enhance this interaction. This in
turn might accelerate the intracellular trafﬁcking of Gag to the
plasma membrane along these structures, although the topological
details are still unknown. Consistent with this observation, a plus-
end microtubule motor KIF4 has been shown previously to associ-
ate with HIV-1 Gag and to enhance Gag trafﬁcking [31,32]. These
results further demonstrate the relevance of microtubule network
in the trafﬁcking of the HIV-1 Gag.
The involvement of the microtubule cytoskeleton in Gag assem-
bly and HIV-1 particle egress is somewhat controversial
[3,26,33,34]. However, several reports have presented convincing
data to indicate the importance of this network in HIV-1 assembly
1250 M. Nishi et al. / FEBS Letters 583 (2009) 1243–1250and propagation [3,35,36]. Our current study further demonstrates
that the microtubule depolymerizing reagent, nocodazole, or the
expression of microtubule-destabilizing protein stathmin, signiﬁ-
cantly inhibits the enhancement of HIV-1 particle production by
SOCS1, suggesting a possible role of the microtubule network in
regular HIV-1 particle production.
Our previous report indicated that the targeted depletion of
SOCS1 results in the prominent perinuclear accumulations of
HIV-1 Gag in 293T cells [11]. Our current study shows that noco-
dazole treatment or stathmin expression only slightly affects Gag
release in non-SOCS1 overexpressing cells. This difference might
be attributable to the following two possibilities. First, SOCS1
may affect Gag at multiple points during trafﬁcking and assembly,
and a critical point could be prior to the microtubule-mediated
events that can be affected by nocodazole or stathmin. Second,
there are multiple pathways to the delivery of exogenously ex-
pressed Gag protein from the cytoplasm to the plasma membrane
in addition to microtubule-directed transport. Furthermore, we are
currently uncertain whether the Gag association with microtu-
bules is mediated by other microtubule binding proteins in cooper-
ation with SOCS1, or whether SOCS1 directly associates with HIV-1
Gag on the microtubules. Further careful analysis must be per-
formed to elucidate these possibilities.
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